AU6465798A - Diagnosing neurologic disorders - Google Patents
Diagnosing neurologic disordersInfo
- Publication number
- AU6465798A AU6465798A AU64657/98A AU6465798A AU6465798A AU 6465798 A AU6465798 A AU 6465798A AU 64657/98 A AU64657/98 A AU 64657/98A AU 6465798 A AU6465798 A AU 6465798A AU 6465798 A AU6465798 A AU 6465798A
- Authority
- AU
- Australia
- Prior art keywords
- neurologic disorders
- diagnosing
- diagnosing neurologic
- disorders
- neurologic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3658697P | 1997-03-14 | 1997-03-14 | |
US60036586 | 1997-03-14 | ||
US6140297P | 1997-09-30 | 1997-09-30 | |
US60061402 | 1997-09-30 | ||
US3793398A | 1998-03-10 | 1998-03-10 | |
US09037933 | 1998-03-10 | ||
PCT/US1998/005045 WO1998040748A1 (en) | 1997-03-14 | 1998-03-13 | Diagnosing neurologic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6465798A true AU6465798A (en) | 1998-09-29 |
Family
ID=27365060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64657/98A Abandoned AU6465798A (en) | 1997-03-14 | 1998-03-13 | Diagnosing neurologic disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6465798A (en) |
WO (1) | WO1998040748A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITFI980099A1 (en) * | 1998-04-27 | 1999-10-27 | Univ Firenze | DIAGNOSTIC METHOD FOR ALGIC PATHOLOGIES |
EP1259818A2 (en) * | 2000-02-24 | 2002-11-27 | Oxford GlycoSciences (UK) Limited | Diagnosis and treatment of schizophrenia |
JP3507884B2 (en) * | 2000-03-07 | 2004-03-15 | 新潟大学長 | Objective diagnosis of schizophrenia using gene expression as an index |
JP2004505609A (en) * | 2000-04-03 | 2004-02-26 | オックスフォード グリコサイエンシズ(ユーケー) リミテッド | Nucleic acid molecules, polypeptides, and uses thereof including diagnosis and treatment of Alzheimer's disease |
BR0112969A (en) | 2000-08-04 | 2004-06-22 | Dmi Biosciences Inc | Method of using diketopiperazines and compositions containing them |
EP1408333A3 (en) * | 2001-10-03 | 2006-10-25 | Pfizer Products Inc. | Diagnosis and treatment of Alzheimer's disease |
US7026129B2 (en) * | 2001-11-23 | 2006-04-11 | Syn X Pharma, Inc. | IG lambda biopolymer markers predictive of Alzheimers disease |
US7179606B2 (en) * | 2001-11-23 | 2007-02-20 | Syn X Pharma, Inc. | IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease |
US7732403B2 (en) | 2003-05-15 | 2010-06-08 | Dmi Biosciences, Inc. | Treatment of T-cell mediated diseases |
CN1300588C (en) * | 2005-02-28 | 2007-02-14 | 上海交通大学 | Method for acquiring plasma specific protein for schizophrenia diagnosis and use thereof |
US8217047B2 (en) | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
GB0915736D0 (en) * | 2009-09-09 | 2009-10-07 | Cambridge Entpr Ltd | Biomarkers |
CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
WO2013055749A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
PL2766029T3 (en) | 2011-10-10 | 2020-08-24 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
JP6231484B2 (en) | 2011-10-28 | 2017-11-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Rhinitis treatment |
CN105101965B (en) | 2013-03-15 | 2021-03-09 | 安皮奥制药股份有限公司 | Compositions for stem cell mobilization, homing, expansion and differentiation and methods of use thereof |
RU2736513C2 (en) | 2014-08-18 | 2020-11-17 | Ампио Фармасьютикалз, Инк. | Treating pathological conditions of joints |
WO2016187317A1 (en) | 2015-05-18 | 2016-11-24 | Georgetown University | Metabolic biomarkers for memory loss |
EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
US10900977B2 (en) | 2015-10-16 | 2021-01-26 | Georgetown University | Protein biomarkers for memory loss |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3587091T2 (en) * | 1984-11-13 | 1993-06-03 | Esa Inc | DEVELOPMENT METHOD FOR DRUG TREATMENT MEDICINES. |
US4874694A (en) * | 1987-04-07 | 1989-10-17 | The Rockefeller University | Use of phosphoprotein patterns for diagnosis of neurological and psychiatric disorders |
DE69214628T2 (en) * | 1991-01-18 | 1997-05-22 | Esa Inc | Method of diagnosing disorders of body functions using biochemical profiles |
AU7556994A (en) * | 1993-08-13 | 1995-03-14 | Molecular Geriatrics Corporation | Methods for the diagnosis of alzheimer's disease |
EP0760098A4 (en) * | 1994-06-09 | 1997-07-16 | Univ Bar Ilan | Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions |
-
1998
- 1998-03-13 AU AU64657/98A patent/AU6465798A/en not_active Abandoned
- 1998-03-13 WO PCT/US1998/005045 patent/WO1998040748A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998040748A1 (en) | 1998-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6465798A (en) | Diagnosing neurologic disorders | |
AU5879198A (en) | Vehicle monitor | |
AU5879098A (en) | Vehicle monitor | |
AU1709299A (en) | Mixer-injectors | |
AU8921698A (en) | Follistatin-3 | |
AU6598798A (en) | Resorcinyl-triazines | |
AU7966098A (en) | Hm74a receptor | |
AU1027499A (en) | 32P-polyphosphazene | |
AU7474198A (en) | Dispenser-applicator assembly | |
AU6827898A (en) | Detergent-package combination | |
AU5272198A (en) | EMP-charge-eliminator | |
AU4632297A (en) | Microcapsules | |
AU9635298A (en) | Fastening device | |
AU4322497A (en) | Car | |
AU2954897A (en) | Beta-lactams | |
AU4117497A (en) | Micropolarimeter | |
AU6998698A (en) | Dioxacycloalkan-8-one | |
AU2752897A (en) | Formazan-based immunoassay | |
AU7761998A (en) | Korrosionsschutzanstrichstoff | |
AU1040999A (en) | Securing mechanism | |
AU8214598A (en) | 3-benzylpiperidine | |
AU5888698A (en) | Refining element | |
AU6090898A (en) | Substituted 4-benzoyl-pyrazoles | |
AU8547698A (en) | Vehicle | |
AU9469798A (en) | Solar-collecting assembly |